Comparative study between perineural and Intravenous Dexamethasone in Ultrasound guided Supraclavicular Brachial Plexus Block for Upper Limb Surgeries

Background: Dexamethasone is utilized clinically to treat different incendiary and immune system sicknesses. However, glucocorticoids are additionally used to treat patients with neuropathic and complex territorial torment conditions. When performing surgery on the upper extremities, a brachial plexus block provides better analgesia and reduces opioid use. Aim: To compare the impact of perineural versus intravenous dexamethasone on the result of ultrasound-directed single-portion supraclavicular brachial plexus block with 0.5% bupivacaine in furthest point subscapular methodology versus intravenous dexamethasone. Patients and Methods: This prospective, double-blind study was conducted at Al-Azhar (Assiut) University Hospitals in 135 adult ASA I and II patients booked for elective lower and furthest point a medical procedure with sensor-directed supraclavicular block. Ultrasound from October 2021 to June 2022. Results: There were no significant differences between the three gatherings regarding age, orientation, ASD, span of a medical procedure, event of masses, hearing rate (beats/minute), mean blood vessel pressure, respiratory rate, and oxygen immersion (Spo2%). There was an exceptionally measurably huge worth of the VAS esteem in the C gathering, which contrasted with the P.N. bunch and the IV gathering, which followed 20 active times. No huge contrast between intravenous and perineural dexamethasone in ultrasound-directed supraclavicular block Conclusion: Perineural and intravenous dexamethasone draw out the span of the absence of pain and decrease the complete portion of salvage narcotics when added to nearby sedatives without tremendous contrasts in the ultrasound-directed supraclavicular mass between them.